THE NEXT STAGE IN CELLULAR THERAPIES

CELLECTIVE BIOTHERAPY

Revolutionizing the treatment of immunological diseases

We are developing first-in-class regulatory B10 cell-based immunotherapies for treating cancers, autoimmunity and immunodeficiency. Our unique technologies can either enhance or inhibit immune responses as needed for disease treatment.

OUR MISSION

 

Our mission is to develop novel immunotherapies that provide patients with improved treatments for cancer, infectious disease, autoimmunity and immunodeficiency.

  • Technology

    We are advancing two B10 cell-based technologies that can either enhance or inhibit immune responses. We believe these have the potential to profoundly advance treatments for inflammation, autoimmunity, solid tumors and infection.

    > Click to read more.

  • Pipeline

    Our first-in-class regulatory B10 cell-directed therapies take a unique approach and distinguish us from others working in the immunotherapy area. We have one of the leading pipelines in B cell therapy.

    > Click to read more.

  • Publications

    The science behind our technology is well-vetted and supported by numerous peer-reviewed publications.

    > Click to read more.

Follow Cellective

Read our latest news.
Have questions? Let's talk.